GenrAb
Company Details
Status: Private
Employees: 1-10
Location:
Dallas, Texas, United States
Type:
sample
Technology:
sample
sample
sample
About: GenrAb, Inc. is harnessing the power of adaptive human immunity to discover neuroprotective and neurotherapeutic human antibodies. Guided by proprietary immunogenetic models, the Company interrogates the cerebrospinal fluid in patients with active neurological disease to harvest novel human disease associated antibodies. Antibodies such as TGM-010, are selected based on their antineuronal capabilities and potential for managing neuronal stress to preserve cell function and survival. Using this unique approach, GenrAb is building a pipeline of patented therapeutic antibodies that can durably reduce disability in patients suffering from neurodegenerative disease, democratizing the availability of even rare antibodies found only in certain patients with neurological disease. GenrAb has been the recipient of multiple accolades, recently featured in the Dallas Morning News, as the North Texas Therapeutics Innovator of the Year, a Texas Biotech Rising Star while winning multiple Golden Ticket awards in highly competitive environments that were sponsored by Boehringer-Ingelheim ('23), and Otsuka Pharmaceuticals ('24).
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
GenrAb | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.